Plasma and cellular fibronectin: distinct and independent functions during tissue repair
Tóm tắt
Từ khóa
Tài liệu tham khảo
Lorenz HP, Longaker MT: Wounds: biology, pathology and management. Surgery, Second Edition Basic Science and Clinical Evidence. 2003, Springer New York, 77-88. Second
Midwood KS, Williams LV, Schwarzbauer JE: Tissue repair and the dynamics of the extracellular matrix. Int J Biochem Cell Biol. 2004, 36: 1031-1037. 10.1016/j.biocel.2003.12.003.
Baneyx G, Baugh L, Vogel V: Coexisting conformations of fibronectin in cell culture imaged using fluorescence resonance energy transfer. Proc Natl Acad Sci USA. 2001, 98: 14464-14468. 10.1073/pnas.251422998.
Baneyx G, Baugh L, Vogel V: Fibronectin extension and unfolding within cell matrix fibrils controlled by cytoskeletal tension. Proc Natl Acad Sci USA. 2002, 99: 5139-5143. 10.1073/pnas.072650799.
Erickson HP, Carrell N, McDonagh J: Fibronectin molecule visualized in electron microscopy: a long, thin, flexible strand. J Cell Biol. 1981, 91: 673-678. 10.1083/jcb.91.3.673.
Erickson HP, Carrell NA: Fibronectin in extended and compact conformations. Electron microscopy and sedimentation analysis. J Biol Chem. 1983, 258: 14539-14544.
Johnson KJ, Sage H, Briscoe G, Erickson HP: The compact conformation of fibronectin is determined by intramolecular ionic interactions. J Biol Chem. 1999, 274: 15473-15479. 10.1074/jbc.274.22.15473.
Rocco M, Infusini E, Daga MG, Gogioso L, Cuniberti C: Models of fibronectin. EMBO J. 1987, 6: 2343-2349.
Pickford AR, Campbell ID: NMR studies of modular protein structures and their interactions. Chem Rev. 2004, 104: 3557-3566. 10.1021/cr0304018.
Karuri NW, Lin Z, Rye HS, Schwarzbauer JE: Probing the conformation of the fibronectin III1-2 domain by fluorescence resonance energy transfer. J Biol Chem. 2009, 284: 3445-3452.
Rocco M, Carson M, Hantgan R, McDonagh J, Hermans J: Dependence of the shape of the plasma fibronectin molecule on solvent composition. Ionic strength and glycerol content. J Biol Chem. 1983, 258: 14545-14549.
Sechler JL, Takada Y, Schwarzbauer JE: Altered rate of fibronectin matrix assembly by deletion of the first type III repeats. J Cell Biol. 1996, 134: 573-583. 10.1083/jcb.134.2.573.
Zardi L, Cecconi C, Barbieri O, Carnemolla B, Picca M, Santi L: Concentration of fibronectin in plasma of tumor-bearing mice and synthesis by Ehrlich ascites tumor cells. Cancer Res. 1979, 39: 3774-3779.
Magnusson MK, Mosher DF: Fibronectin: structure, assembly, and cardiovascular implications. Arterioscler Thromb Vasc Biol. 1998, 18: 1363-1370. 10.1161/01.ATV.18.9.1363.
Tressel T, McCarthy JB, Calaycay J, Lee TD, Legesse K, Shively JE, Pande H: Human plasma fibronectin. Demonstration of structural differences between the A- and B-chains in the III CS region. Biochem J. 1991, 274 (Pt 3): 731-738.
Wilson CL, Schwarzbauer JE: The alternatively spliced V region contributes to the differential incorporation of plasma and cellular fibronectins into fibrin clots. J Cell Biol. 1992, 119: 923-933. 10.1083/jcb.119.4.923.
Chauhan AK, Kisucka J, Cozzi MR, Walsh MT, Moretti FA, Battiston M, Mazzucato M, De Marco L, Baralle FE, Wagner DD, Muro AF: Prothrombotic effects of fibronectin isoforms containing the EDA domain. Arterioscler Thromb Vasc Biol. 2008, 28: 296-301.
Peters JH, Loredo GA, Chen G, Maunder R, Hahn TJ, Willits NH, Hynes RO: Plasma levels of fibronectin bearing the alternatively spliced EIIIB segment are increased after major trauma. J Lab Clin Med. 2003, 141: 401-410. 10.1016/S0022-2143(03)00042-8.
Castellanos M, Leira R, Serena J, Blanco M, Pedraza S, Castillo J, Davalos A: Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke. Stroke. 2004, 35: 1671-1676. 10.1161/01.STR.0000131656.47979.39.
Song KS, Kim HK, Shim W, Jee SH: Plasma fibronectin levels in ischemic heart disease. Atherosclerosis. 2001, 154: 449-453. 10.1016/S0021-9150(00)00490-1.
Claudepierre P, Allanore Y, Belec L, Larget-Piet B, Zardi L, Chevalier X: Increased Ed-B fibronectin plasma levels in spondyloarthropathies: comparison with rheumatoid arthritis patients and a healthy population. Rheumatology (Oxford). 1999, 38: 1099-1103. 10.1093/rheumatology/38.11.1099.
Mao Y, Schwarzbauer JE: Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol. 2005, 24: 389-399. 10.1016/j.matbio.2005.06.008.
Hershberger RP, Culp LA: Cell-type-specific expression of alternatively spliced human fibronectin IIICS mRNAs. Mol Cell Biol. 1990, 10: 662-671.
Khan ZA, Chan BM, Uniyal S, Barbin YP, Farhangkhoee H, Chen S, Chakrabarti S: EDB fibronectin and angiogenesis-a novel mechanistic pathway. Angiogenesis. 2005, 8: 183-196. 10.1007/s10456-005-9017-6.
Rybak JN, Roesli C, Kaspar M, Villa A, Neri D: The extra-domain A of fibronectin is a vascular marker of solid tumors and metastases. Cancer Res. 2007, 67: 10948-10957. 10.1158/0008-5472.CAN-07-1436.
Van Vliet A, Baelde HJ, Vleming LJ, de Heer E, Bruijn JA: Distribution of fibronectin isoforms in human renal disease. J Pathol. 2001, 193: 256-262. 10.1002/1096-9896(2000)9999:9999<::AID-PATH783>3.0.CO;2-P.
ffrench-Constant C: Alternative splicing of fibronectin-many different proteins but few different functions. Exp Cell Res. 1995, 221: 261-271. 10.1006/excr.1995.1374.
Altroff H, Schlinkert R, van der Walle CF, Bernini A, Campbell ID, Werner JM, Mardon HJ: Interdomain tilt angle determines integrin-dependent function of the ninth and tenth FIII domains of human fibronectin. J Biol Chem. 2004, 279: 55995-56003. 10.1074/jbc.M406976200.
Bencharit S, Cui CB, Siddiqui A, Howard-Williams EL, Sondek J, Zuobi-Hasona K, Aukhil I: Structural insights into fibronectin type III domain-mediated signaling. J Mol Biol. 2007, 367: 303-309. 10.1016/j.jmb.2006.10.017.
Leahy DJ, Aukhil I, Erickson HP: 2.0 A crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region. Cell. 1996, 84: 155-164. 10.1016/S0092-8674(00)81002-8.
Pickford AR, Smith SP, Staunton D, Boyd J, Campbell ID: The hairpin structure of the (6)F1(1)F2(2)F2 fragment from human fibronectin enhances gelatin binding. EMBO J. 2001, 20: 1519-1529. 10.1093/emboj/20.7.1519.
Spitzfaden C, Grant RP, Mardon HJ, Campbell ID: Module-module interactions in the cell binding region of fibronectin: stability, flexibility and specificity. J Mol Biol. 1997, 265: 565-579. 10.1006/jmbi.1996.0736.
Ventura E, Sassi F, Parodi A, Balza E, Borsi L, Castellani P, Carnemolla B, Zardi L: Alternative splicing of the angiogenesis associated extra-domain B of fibronectin regulates the accessibility of the B-C loop of the type III repeat 8. PLoS One. 5: e9145.
Armstrong PB, Armstrong MT: Intercellular invasion and the organizational stability of tissues: a role for fibronectin. Biochim Biophys Acta. 2000, 1470: O9-20.
Corbett SA, Lee L, Wilson CL, Schwarzbauer JE: Covalent cross-linking of fibronectin to fibrin is required for maximal cell adhesion to a fibronectin-fibrin matrix. J Biol Chem. 1997, 272: 24999-25005. 10.1074/jbc.272.40.24999.
Matsuka YV, Migliorini MM, Ingham KC: Cross-linking of fibronectin to C-terminal fragments of the fibrinogen alpha-chain by factor XIIIa. J Protein Chem. 1997, 16: 739-745. 10.1023/A:1026307731751.
Cho J, Degen JL, Coller BS, Mosher DF: Fibrin but not adsorbed fibrinogen supports fibronectin assembly by spread platelets. Effects of the interaction of alphaIIb beta3 with the C terminus of the fibrinogen gamma-chain. J Biol Chem. 2005, 280: 35490-35498. 10.1074/jbc.M506289200.
Plow EF, Birdwell C, Ginsberg MH: Identification and quantitation of platelet-associated fibronectin antigen. J Clin Invest. 1979, 63: 540-543. 10.1172/JCI109334.
Olorundare OE, Peyruchaud O, Albrecht RM, Mosher DF: Assembly of a fibronectin matrix by adherent platelets stimulated by lysophosphatidic acid and other agonists. Blood. 2001, 98: 117-124. 10.1182/blood.V98.1.117.
Niewiarowska J, Cierniewski CS, Tuszynski GP: Association of fibronectin with the platelet cytoskeleton. J Biol Chem. 1984, 259: 6181-6187.
Thurlow PJ, Kenneally DA, Connellan JM: The role of fibronectin in platelet aggregation. Br J Haematol. 1990, 75: 549-556. 10.1111/j.1365-2141.1990.tb07797.x.
Gardner JM, Hynes RO: Interaction of fibronectin with its receptor on platelets. Cell. 1985, 42: 439-448. 10.1016/0092-8674(85)90101-1.
Plow EF, Marguerie GA, Ginsberg MH: Fibronectin binding to thrombin-stimulated platelets: evidence for fibrin(ogen) independent and dependent pathways. Blood. 1985, 66: 26-32.
Watson SP: Platelet activation by extracellular matrix proteins in haemostasis and thrombosis. Curr Pharm Des. 2009, 15: 1358-1372. 10.2174/138161209787846702.
Schick PK, Wojensk CM, Bennett V, Denisova L: Fibronectin isoforms in megakaryocytes. Stem Cells. 1996, 14 (Suppl 1): 212-219.
Ni H, Denis CV, Subbarao S, Degen JL, Sato TN, Hynes RO, Wagner DD: Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest. 2000, 106: 385-392. 10.1172/JCI9896.
Ni H, Papalia JM, Degen JL, Wagner DD: Control of thrombus embolization and fibronectin internalization by integrin alpha IIb beta 3 engagement of the fibrinogen gamma chain. Blood. 2003, 102: 3609-3614. 10.1182/blood-2003-03-0850.
Ni H, Yuen PS, Papalia JM, Trevithick JE, Sakai T, Fassler R, Hynes RO, Wagner DD: Plasma fibronectin promotes thrombus growth and stability in injured arterioles. Proc Natl Acad Sci USA. 2003, 100: 2415-2419. 10.1073/pnas.2628067100.
Wencel-Drake JD, Painter RG, Zimmerman TS, Ginsberg MH: Ultrastructural localization of human platelet thrombospondin, fibrinogen, fibronectin, and von Willebrand factor in frozen thin section. Blood. 1985, 65: 929-938.
Sakai T, Johnson KJ, Murozono M, Sakai K, Magnuson MA, Wieloch T, Cronberg T, Isshiki A, Erickson HP, Fassler R: Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis. Nat Med. 2001, 7: 324-330. 10.1038/85471.
Matuskova J, Chauhan AK, Cambien B, Astrof S, Dole VS, Piffath CL, Hynes RO, Wagner DD: Decreased plasma fibronectin leads to delayed thrombus growth in injured arterioles. Arterioscler Thromb Vasc Biol. 2006, 26: 1391-1396. 10.1161/01.ATV.0000216282.58291.c6.
Kamykowski GW, Mosher DF, Lorand L, Ferry JD: Modification of shear modulus and creep compliance of fibrin clots by fibronectin. Biophys Chem. 1981, 13: 25-28. 10.1016/0301-4622(81)80021-X.
Cho J, Mosher DF: Enhancement of thrombogenesis by plasma fibronectin cross-linked to fibrin and assembled in platelet thrombi. Blood. 2006, 107: 3555-3563. 10.1182/blood-2005-10-4168.
Tonnesen MG, Feng X, Clark RA: Angiogenesis in wound healing. J Investig Dermatol Symp Proc. 2000, 5: 40-46. 10.1046/j.1087-0024.2000.00014.x.
Knox P, Crooks S, Rimmer CS: Role of fibronectin in the migration of fibroblasts into plasma clots. J Cell Biol. 1986, 102: 2318-2323. 10.1083/jcb.102.6.2318.
Manabe R, Ohe N, Maeda T, Fukuda T, Sekiguchi K: Modulation of cell-adhesive activity of fibronectin by the alternatively spliced EDA segment. J Cell Biol. 1997, 139: 295-307. 10.1083/jcb.139.1.295.
Sottile J, Mosher DF: N-terminal type I modules required for fibronectin binding to fibroblasts and to fibronectin's III1 module. Biochem J. 1997, 323 (Pt 1): 51-60.
Wang R, Clark RA, Mosher DF, Ren XD: Fibronectin's central cell-binding domain supports focal adhesion formation and Rho signal transduction. J Biol Chem. 2005, 280: 28803-28810. 10.1074/jbc.M501421200.
Friedland JC, Lee MH, Boettiger D: Mechanically activated integrin switch controls alpha5beta1 function. Science. 2009, 323: 642-644. 10.1126/science.1168441.
Sottile J, Hocking DC: Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Mol Biol Cell. 2002, 13: 3546-3559. 10.1091/mbc.E02-01-0048.
Cukierman E, Pankov R, Stevens DR, Yamada KM: Taking cell-matrix adhesions to the third dimension. Science. 2001, 294: 1708-1712. 10.1126/science.1064829.
Johansson S, Svineng G, Wennerberg K, Armulik A, Lohikangas L: Fibronectin-integrin interactions. Front Biosci. 1997, 2: d126-146.
Schnapp LM, Hatch N, Ramos DM, Klimanskaya IV, Sheppard D, Pytela R: The human integrin alpha 8 beta 1 functions as a receptor for tenascin, fibronectin, and vitronectin. J Biol Chem. 1995, 270: 23196-23202. 10.1074/jbc.270.39.23196.
Liao YF, Gotwals PJ, Koteliansky VE, Sheppard D, Van De Water L: The EIIIA segment of fibronectin is a ligand for integrins alpha 9beta 1 and alpha 4beta 1 providing a novel mechanism for regulating cell adhesion by alternative splicing. J Biol Chem. 2002, 277: 14467-14474. 10.1074/jbc.M201100200.
Repesh LA, Fitzgerald TJ, Furcht LT: Fibronectin involvement in granulation tissue and wound healing in rabbits. J Histochem Cytochem. 1982, 30: 351-358. 10.1177/30.4.6174568.
Dallas SL, Sivakumar P, Jones CJ, Chen Q, Peters DM, Mosher DF, Humphries MJ, Kielty CM: Fibronectin regulates latent transforming growth factor-beta (TGF beta) by controlling matrix assembly of latent TGF beta-binding protein-1. J Biol Chem. 2005, 280: 18871-18880. 10.1074/jbc.M410762200.
Chiang HY, Korshunov VA, Serour A, Shi F, Sottile J: Fibronectin is an important regulator of flow-induced vascular remodeling. Arterioscler Thromb Vasc Biol. 2009, 29: 1074-1079. 10.1161/ATVBAHA.108.181081. Epub 2009 Apr 1030
Dzamba BJ, Peters DM: Arrangement of cellular fibronectin in noncollagenous fibrils in human fibroblast cultures. J Cell Sci. 1991, 100 (Pt 3): 605-612.
Dzamba BJ, Wu H, Jaenisch R, Peters DM: Fibronectin binding site in type I collagen regulates fibronectin fibril formation. J Cell Biol. 1993, 121: 1165-1172. 10.1083/jcb.121.5.1165.
Li S, Van Den Diepstraten C, D'Souza SJ, Chan BM, Pickering JG: Vascular smooth muscle cells orchestrate the assembly of type I collagen via alpha2beta1 integrin, RhoA, and fibronectin polymerization. Am J Pathol. 2003, 163: 1045-1056. 10.1016/S0002-9440(10)63464-5.
McDonald JA, Kelley DG, Broekelmann TJ: Role of fibronectin in collagen deposition: Fab' to the gelatin-binding domain of fibronectin inhibits both fibronectin and collagen organization in fibroblast extracellular matrix. J Cell Biol. 1982, 92: 485-492. 10.1083/jcb.92.2.485.
Sottile J, Shi F, Rublyevska I, Chiang HY, Lust J, Chandler J: Fibronectin-dependent collagen I deposition modulates the cell response to fibronectin. Am J Physiol Cell Physiol. 2007, 293: C1934-1946. 10.1152/ajpcell.00130.2007.
Velling T, Risteli J, Wennerberg K, Mosher DF, Johansson S: Polymerization of type I and III collagens is dependent on fibronectin and enhanced by integrins alpha 11beta 1 and alpha 2beta 1. J Biol Chem. 2002, 277: 37377-37381. 10.1074/jbc.M206286200.
Pereira M, Rybarczyk BJ, Odrljin TM, Hocking DC, Sottile J, Simpson-Haidaris PJ: The incorporation of fibrinogen into extracellular matrix is dependent on active assembly of a fibronectin matrix. J Cell Sci. 2002, 115: 609-617.
Czirok A, Zamir EA, Filla MB, Little CD, Rongish BJ: Extracellular matrix macroassembly dynamics in early vertebrate embryos. Curr Top Dev Biol. 2006, 73: 237-258.
Kinsey R, Williamson MR, Chaudhry S, Mellody KT, McGovern A, Takahashi S, Shuttleworth CA, Kielty CM: Fibrillin-1 microfibril deposition is dependent on fibronectin assembly. J Cell Sci. 2008, 121: 2696-2704. 10.1242/jcs.029819.
Sabatier L, Chen D, Fagotto-Kaufmann C, Hubmacher D, McKee MD, Annis DS, Mosher DF, Reinhardt DP: Fibrillin assembly requires fibronectin. Mol Biol Cell. 2009, 20: 846-858.
Godyna S, Mann DM, Argraves WS: A quantitative analysis of the incorporation of fibulin-1 into extracellular matrix indicates that fibronectin assembly is required. Matrix Biol. 1995, 14: 467-477. 10.1016/0945-053X(95)90004-7.
Bazigou E, Xie S, Chen C, Weston A, Miura N, Sorokin L, Adams R, Muro AF, Sheppard D, Makinen T: Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev Cell. 2009, 17: 175-186. 10.1016/j.devcel.2009.06.017.
Chung CY, Zardi L, Erickson HP: Binding of tenascin-C to soluble fibronectin and matrix fibrils. J Biol Chem. 1995, 270: 29012-29017. 10.1074/jbc.270.48.29012.
Ramos DM, Chen B, Regezi J, Zardi L, Pytela R: Tenascin-C matrix assembly in oral squamous cell carcinoma. Int J Cancer. 1998, 75: 680-687. 10.1002/(SICI)1097-0215(19980302)75:5<680::AID-IJC4>3.0.CO;2-V.
Huang G, Zhang Y, Kim B, Ge G, Annis DS, Mosher DF, Greenspan DS: Fibronectin binds and enhances the activity of bone morphogenetic protein 1. J Biol Chem. 2009, 284: 25879-25888. 10.1074/jbc.M109.024125.
Wijelath ES, Rahman S, Namekata M, Murray J, Nishimura T, Mostafavi-Pour Z, Patel Y, Suda Y, Humphries MJ, Sobel M: Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism. Circ Res. 2006, 99: 853-860. 10.1161/01.RES.0000246849.17887.66.
Dallas SL, Chen Q, Sivakumar P: Dynamics of assembly and reorganization of extracellular matrix proteins. Curr Top Dev Biol. 2006, 75: 1-24.
Koli K, Hyytiainen M, Ryynanen MJ, Keski-Oja J: Sequential deposition of latent TGF-beta binding proteins (LTBPs) during formation of the extracellular matrix in human lung fibroblasts. Exp Cell Res. 2005, 310: 370-382. 10.1016/j.yexcr.2005.08.008.
Sivakumar P, Czirok A, Rongish BJ, Divakara VP, Wang YP, Dallas SL: New insights into extracellular matrix assembly and reorganization from dynamic imaging of extracellular matrix proteins in living osteoblasts. J Cell Sci. 2006, 119: 1350-1360. 10.1242/jcs.02830.
Sottile J, Chandler J: Fibronectin matrix turnover occurs through a caveolin-1-dependent process. Mol Biol Cell. 2005, 16: 757-768.
Serini G, Bochaton-Piallat ML, Ropraz P, Geinoz A, Borsi L, Zardi L, Gabbiani G: The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol. 1998, 142: 873-881. 10.1083/jcb.142.3.873.
Muro AF, Chauhan AK, Gajovic S, Iaconcig A, Porro F, Stanta G, Baralle FE: Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan. J Cell Biol. 2003, 162: 149-160. 10.1083/jcb.200212079.
Hashimoto-Uoshima M, Yan YZ, Schneider G, Aukhil I: The alternatively spliced domains EIIIB and EIIIA of human fibronectin affect cell adhesion and spreading. J Cell Sci. 1997, 110 (Pt 18): 2271-2280.
Chen W, Culp LA: Adhesion mediated by fibronectin's alternatively spliced EDb (EIIIB) and its neighboring type III repeats. Exp Cell Res. 1996, 223: 9-19. 10.1006/excr.1996.0053.
Fukuda T, Yoshida N, Kataoka Y, Manabe R, Mizuno-Horikawa Y, Sato M, Kuriyama K, Yasui N, Sekiguchi K: Mice lacking the EDB segment of fibronectin develop normally but exhibit reduced cell growth and fibronectin matrix assembly in vitro. Cancer Res. 2002, 62: 5603-5610.
Guan JL, Trevithick JE, Hynes RO: Retroviral expression of alternatively spliced forms of rat fibronectin. J Cell Biol. 1990, 110: 833-847. 10.1083/jcb.110.3.833.
Singh P, Reimer CL, Peters JH, Stepp MA, Hynes RO, Van De Water L: The spatial and temporal expression patterns of integrin alpha9beta1 and one of its ligands, the EIIIA segment of fibronectin, in cutaneous wound healing. J Invest Dermatol. 2004, 123: 1176-1181. 10.1111/j.0022-202X.2004.23485.x.
Kalluri R: Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer. 2003, 3: 422-433. 10.1038/nrc1094.
Fernandez-Sauze S, Grall D, Cseh B, Van Obberghen-Schilling E: Regulation of fibronectin matrix assembly and capillary morphogenesis in endothelial cells by Rho family GTPases. Exp Cell Res. 2009, 315: 2092-2104. 10.1016/j.yexcr.2009.03.017.
Jarnagin WR, Rockey DC, Koteliansky VE, Wang SS, Bissell DM: Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol. 1994, 127: 2037-2048. 10.1083/jcb.127.6.2037.
Clark RA, An JQ, Greiling D, Khan A, Schwarzbauer JE: Fibroblast migration on fibronectin requires three distinct functional domains. J Invest Dermatol. 2003, 121: 695-705. 10.1046/j.1523-1747.2003.12484.x.
Wakui S, Furusato M, Nikaido T, Yokota K, Sekiguchi J, Ohmori K, Kano Y, Ushigome S: Ultrastructural localization of fibronectin and laminin in human granulation tissue in relation to capillary development. Cell Struct Funct. 1990, 15: 201-210. 10.1247/csf.15.201.
Gui L, Wojciechowski K, Gildner CD, Nedelkovska H, Hocking DC: Identification of the heparin-binding determinants within fibronectin repeat III1: role in cell spreading and growth. J Biol Chem. 2006, 281: 34816-34825. 10.1074/jbc.M608611200.
Jiang ST, Chiang HC, Cheng MH, Yang TP, Chuang WJ, Tang MJ: Role of fibronectin deposition in cystogenesis of Madin-Darby canine kidney cells. Kidney Int. 1999, 56: 92-103.
Sechler JL, Schwarzbauer JE: Control of cell cycle progression by fibronectin matrix architecture. J Biol Chem. 1998, 273: 25533-25536. 10.1074/jbc.273.40.25533.
Couchman JR, Rees DA, Green MR, Smith CG: Fibronectin has a dual role in locomotion and anchorage of primary chick fibroblasts and can promote entry into the division cycle. J Cell Biol. 1982, 93: 402-410. 10.1083/jcb.93.2.402.
Hocking DC, Chang CH: Fibronectin matrix polymerization regulates small airway epithelial cell migration. Am J Physiol Lung Cell Mol Physiol. 2003, 285: L169-179.
Rozario T, Dzamba B, Weber GF, Davidson LA, DeSimone DW: The physical state of fibronectin matrix differentially regulates morphogenetic movements in vivo. Dev Biol. 2009, 327: 386-398. 10.1016/j.ydbio.2008.12.025.
Natal C, Oses-Prieto JA, Pelacho B, Iraburu MJ, Lopez-Zabalza MJ: Regulation of apoptosis by peptides of fibronectin in human monocytes. Apoptosis. 2006, 11: 209-219. 10.1007/s10495-006-3761-y.
Tafolla E, Wang S, Wong B, Leong J, Kapila YL: JNK1 and JNK2 oppositely regulate p53 in signaling linked to apoptosis triggered by an altered fibronectin matrix: JNK links FAK and p53. J Biol Chem. 2005, 280: 19992-19999. 10.1074/jbc.M500331200.
Zhou X, Rowe RG, Hiraoka N, George JP, Wirtz D, Mosher DF, Virtanen I, Chernousov MA, Weiss SJ: Fibronectin fibrillogenesis regulates three-dimensional neovessel formation. Genes Dev. 2008, 22: 1231-1243. 10.1101/gad.1643308.
Kaczmarek J, Castellani P, Nicolo G, Spina B, Allemanni G, Zardi L: Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int J Cancer. 1994, 59: 11-16. 10.1002/ijc.2910590104.
Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA: Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002, 3: 349-363. 10.1038/nrm809.
Gabbiani G: The Evolution of the Myofibroblast Concept: a Key Cell for Wound Healing and fibrotic diseases. I processi di repiarazione e fibrosi. Giornale di Gerontologia. 2004, 52: 280-282.
Hinz B: Masters and servants of the force: the role of matrix adhesions in myofibroblast force perception and transmission. Eur J Cell Biol. 2006, 85: 175-181. 10.1016/j.ejcb.2005.09.004.
Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G: The myofibroblast: one function, multiple origins. Am J Pathol. 2007, 170: 1807-1816. 10.2353/ajpath.2007.070112.
Hayman EG, Ruoslahti E: Distribution of fetal bovine serum fibronectin and endogenous rat cell fibronectin in extracellular matrix. J Cell Biol. 1979, 83: 255-259. 10.1083/jcb.83.1.255.
Mao Y, Schwarzbauer JE: Stimulatory effects of a three-dimensional microenvironment on cell-mediated fibronectin fibrillogenesis. J Cell Sci. 2005, 118: 4427-4436. 10.1242/jcs.02566.
Peters DM, Portz LM, Fullenwider J, Mosher DF: Co-assembly of plasma and cellular fibronectins into fibrils in human fibroblast cultures. J Cell Biol. 1990, 111: 249-256. 10.1083/jcb.111.1.249.
Tate CC, Garcia AJ, LaPlaca MC: Plasma fibronectin is neuroprotective following traumatic brain injury. Exp Neurol. 2007, 207: 13-22. 10.1016/j.expneurol.2007.05.008. Epub 2007 May 2018
Tan MH, Sun Z, Opitz SL, Schmidt TE, Peters JH, George EL: Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis. Blood. 2004, 104: 11-18. 10.1182/blood-2003-09-3363. Epub 2004 Feb 2019
Mosher DF, Johnson RB: Specificity of fibronectin-fibrin cross-linking. Ann N Y Acad Sci. 1983, 408: 583-594. 10.1111/j.1749-6632.1983.tb23275.x.
Smith ML, Gourdon D, Little WC, Kubow KE, Eguiluz RA, Luna-Morris S, Vogel V: Force-induced unfolding of fibronectin in the extracellular matrix of living cells. PLoS Biol. 2007, 5: e268-10.1371/journal.pbio.0050268.
Choi MG, Hynes RO: Biosynthesis and processing of fibronectin in NIL.8 hamster cells. J Biol Chem. 1979, 254: 12050-12055.
McKeown-Longo PJ, Mosher DF: Binding of plasma fibronectin to cell layers of human skin fibroblasts. J Cell Biol. 1983, 97: 466-472. 10.1083/jcb.97.2.466.
Schwarzbauer JE: Identification of the fibronectin sequences required for assembly of a fibrillar matrix. J Cell Biol. 1991, 113: 1463-1473. 10.1083/jcb.113.6.1463.
Singh P, Carraher C, Schwarzbauer JE: Assembly of fibronectin extracellular matrix. Annu Rev Cell Dev Biol. 26: 397-419.
Takahashi S, Leiss M, Moser M, Ohashi T, Kitao T, Heckmann D, Pfeifer A, Kessler H, Takagi J, Erickson HP, Fassler R: The RGD motif in fibronectin is essential for development but dispensable for fibril assembly. J Cell Biol. 2007, 178: 167-178. 10.1083/jcb.200703021.
Yang JT, Rayburn H, Hynes RO: Embryonic mesodermal defects in alpha 5 integrin-deficient mice. Development. 1993, 119: 1093-1105.
Yang JT, Bader BL, Kreidberg JA, Ullman-Cullere M, Trevithick JE, Hynes RO: Overlapping and independent functions of fibronectin receptor integrins in early mesodermal development. Dev Biol. 1999, 215: 264-277. 10.1006/dbio.1999.9451.
McKeown-Longo PJ, Mosher DF: Interaction of the 70,000-mol-wt amino-terminal fragment of fibronectin with the matrix-assembly receptor of fibroblasts. J Cell Biol. 1985, 100: 364-374. 10.1083/jcb.100.2.364.
Tomasini-Johansson BR, Annis DS, Mosher DF: The N-terminal 70-kDa fragment of fibronectin binds to cell surface fibronectin assembly sites in the absence of intact fibronectin. Matrix Biol. 2006, 25: 282-293. 10.1016/j.matbio.2006.02.002.
Allio AE, McKeown-Longo PJ: Extracellular matrix assembly of cell-derived and plasma-derived fibronectins by substrate-attached fibroblasts. J Cell Physiol. 1988, 135: 459-466. 10.1002/jcp.1041350313.
Bultmann H, Santas AJ, Peters DM: Fibronectin fibrillogenesis involves the heparin II binding domain of fibronectin. J Biol Chem. 1998, 273: 2601-2609. 10.1074/jbc.273.5.2601.
McDonald JA, Quade BJ, Broekelmann TJ, LaChance R, Forsman K, Hasegawa E, Akiyama S: Fibronectin's cell-adhesive domain and an amino-terminal matrix assembly domain participate in its assembly into fibroblast pericellular matrix. J Biol Chem. 1987, 262: 2957-2967.
Morla A, Ruoslahti E: A fibronectin self-assembly site involved in fibronectin matrix assembly: reconstruction in a synthetic peptide. J Cell Biol. 1992, 118: 421-429. 10.1083/jcb.118.2.421.
Zhang Q, Mosher DF: Cross-linking of the NH2-terminal region of fibronectin to molecules of large apparent molecular mass. Characterization of fibronectin assembly sites induced by the treatment of fibroblasts with lysophosphatidic acid. J Biol Chem. 1996, 271: 33284-33292. 10.1074/jbc.271.52.33284.
Pankov R, Cukierman E, Katz BZ, Matsumoto K, Lin DC, Lin S, Hahn C, Yamada KM: Integrin dynamics and matrix assembly: tensin-dependent translocation of alpha(5)beta(1) integrins promotes early fibronectin fibrillogenesis. J Cell Biol. 2000, 148: 1075-1090. 10.1083/jcb.148.5.1075.
Zamir E, Katz BZ, Aota S, Yamada KM, Geiger B, Kam Z: Molecular diversity of cell-matrix adhesions. J Cell Sci. 1999, 112 (Pt 11): 1655-1669.
Curnis F, Longhi R, Crippa L, Cattaneo A, Dondossola E, Bachi A, Corti A: Spontaneous formation of L-isoaspartate and gain of function in fibronectin. J Biol Chem. 2006, 281: 36466-36476. 10.1074/jbc.M604812200.
Xu J, Maurer LM, Hoffmann BR, Annis DS, Mosher DF: iso-DGR sequences do not mediate binding of fibronectin N-terminal modules to adherent fibronectin-null fibroblasts. J Biol Chem. 285: 8563-8571.
Millard CJ, Ellis IR, Pickford AR, Schor AM, Schor SL, Campbell ID: The role of the fibronectin IGD motif in stimulating fibroblast migration. J Biol Chem. 2007, 282: 35530-35535. 10.1074/jbc.M707532200.
Green JA, Berrier AL, Pankov R, Yamada KM: beta1 integrin cytoplasmic domain residues selectively modulate fibronectin matrix assembly and cell spreading through talin and Akt-1. J Biol Chem. 2009, 284: 8148-8159. 10.1074/jbc.M805934200.
Huveneers S, Truong H, Fassler R, Sonnenberg A, Danen EH: Binding of soluble fibronectin to integrin alpha5 beta1-link to focal adhesion redistribution and contractile shape. J Cell Sci. 2008, 121: 2452-2462. 10.1242/jcs.033001.
Takagi J, Strokovich K, Springer TA, Walz T: Structure of integrin alpha5beta1 in complex with fibronectin. EMBO J. 2003, 22: 4607-4615. 10.1093/emboj/cdg445.
Wennerberg K, Lohikangas L, Gullberg D, Pfaff M, Johansson S, Fassler R: Beta 1 integrin-dependent and -independent polymerization of fibronectin. J Cell Biol. 1996, 132: 227-238. 10.1083/jcb.132.1.227.
Wu C, Bauer JS, Juliano RL, McDonald JA: The alpha 5 beta 1 integrin fibronectin receptor, but not the alpha 5 cytoplasmic domain, functions in an early and essential step in fibronectin matrix assembly. J Biol Chem. 1993, 268: 21883-21888.
Wu C, Keivens VM, O'Toole TE, McDonald JA, Ginsberg MH: Integrin activation and cytoskeletal interaction are essential for the assembly of a fibronectin matrix. Cell. 1995, 83: 715-724. 10.1016/0092-8674(95)90184-1.
Darribere T, Guida K, Larjava H, Johnson KE, Yamada KM, Thiery JP, Boucaut JC: In vivo analyses of integrin beta 1 subunit function in fibronectin matrix assembly. J Cell Biol. 1990, 110: 1813-1823. 10.1083/jcb.110.5.1813.
Winklbauer R, Stoltz C: Fibronectin fibril growth in the extracellular matrix of the Xenopus embryo. J Cell Sci. 1995, 108 (Pt 4): 1575-1586.
Disatnik MH, Rando TA: Integrin-mediated muscle cell spreading. The role of protein kinase c in outside-in and inside-out signaling and evidence of integrin cross-talk. J Biol Chem. 1999, 274: 32486-32492. 10.1074/jbc.274.45.32486.
Lee SE, Kamm RD, Mofrad MR: Force-induced activation of talin and its possible role in focal adhesion mechanotransduction. J Biomech. 2007, 40: 2096-2106. 10.1016/j.jbiomech.2007.04.006.
Somanath PR, Kandel ES, Hay N, Byzova TV: Akt1 signaling regulates integrin activation, matrix recognition, and fibronectin assembly. J Biol Chem. 2007, 282: 22964-22976. 10.1074/jbc.M700241200.
Julich D, Mould AP, Koper E, Holley SA: Control of extracellular matrix assembly along tissue boundaries via Integrin and Eph/Ephrin signaling. Development. 2009, 136: 2913-2921. 10.1242/dev.038935.
Woods A, Longley RL, Tumova S, Couchman JR: Syndecan-4 binding to the high affinity heparin-binding domain of fibronectin drives focal adhesion formation in fibroblasts. Arch Biochem Biophys. 2000, 374: 66-72. 10.1006/abbi.1999.1607.
Chung CY, Erickson HP: Glycosaminoglycans modulate fibronectin matrix assembly and are essential for matrix incorporation of tenascin-C. J Cell Sci. 1997, 110 (Pt 12): 1413-1419.
Ingham KC, Brew SA, Atha DH: Interaction of heparin with fibronectin and isolated fibronectin domains. Biochem J. 1990, 272: 605-611.
Bloom L, Ingham KC, Hynes RO: Fibronectin regulates assembly of actin filaments and focal contacts in cultured cells via the heparin-binding site in repeat III13. Mol Biol Cell. 1999, 10: 1521-1536.
Busby TF, Argraves WS, Brew SA, Pechik I, Gilliland GL, Ingham KC: Heparin binding by fibronectin module III-13 involves six discontinuous basic residues brought together to form a cationic cradle. J Biol Chem. 1995, 270: 18558-18562. 10.1074/jbc.270.31.18558.
Ingham KC, Brew SA, Migliorini MM, Busby TF: Binding of heparin by type III domains and peptides from the carboxy terminal hep-2 region of fibronectin. Biochemistry. 1993, 32: 12548-12553. 10.1021/bi00097a035.
Arrington CB, Yost HJ: Extra-embryonic syndecan 2 regulates organ primordia migration and fibrillogenesis throughout the zebrafish embryo. Development. 2009, 136: 3143-3152. 10.1242/dev.031492.
Klass CM, Couchman JR, Woods A: Control of extracellular matrix assembly by syndecan-2 proteoglycan. J Cell Sci. 2000, 113 (Pt 3): 493-506.
Geiger B, Bershadsky A, Pankov R, Yamada KM: Transmembrane crosstalk between the extracellular matrix-cytoskeleton crosstalk. Nat Rev Mol Cell Biol. 2001, 2: 793-805. 10.1038/35099066.
Ohashi T, Kiehart DP, Erickson HP: Dual labeling of the fibronectin matrix and actin cytoskeleton with green fluorescent protein variants. J Cell Sci. 2002, 115: 1221-1229.
Lemmon CA, Chen CS, Romer LH: Cell traction forces direct fibronectin matrix assembly. Biophys J. 2009, 96: 729-738. 10.1016/j.bpj.2008.10.009.
Davidson LA, Dzamba BD, Keller R, Desimone DW: Live imaging of cell protrusive activity, and extracellular matrix assembly and remodeling during morphogenesis in the frog, Xenopus laevis. Dev Dyn. 2008, 237: 2684-2692. 10.1002/dvdy.21600.
Zhong C, Chrzanowska-Wodnicka M, Brown J, Shaub A, Belkin AM, Burridge K: Rho-mediated contractility exposes a cryptic site in fibronectin and induces fibronectin matrix assembly. J Cell Biol. 1998, 141: 539-551. 10.1083/jcb.141.2.539.
Yoneda A, Ushakov D, Multhaupt HA, Couchman JR: Fibronectin matrix assembly requires distinct contributions from Rho kinases I and -II. Mol Biol Cell. 2007, 18: 66-75.
Zhang Q, Magnusson MK, Mosher DF: Lysophosphatidic acid and microtubule-destabilizing agents stimulate fibronectin matrix assembly through Rho-dependent actin stress fiber formation and cell contraction. Mol Biol Cell. 1997, 8: 1415-1425.
Brenner KA, Corbett SA, Schwarzbauer JE: Regulation of fibronectin matrix assembly by activated Ras in transformed cells. Oncogene. 2000, 19: 3156-3163. 10.1038/sj.onc.1203626.
Meshel AS, Wei Q, Adelstein RS, Sheetz MP: Basic mechanism of three-dimensional collagen fibre transport by fibroblasts. Nat Cell Biol. 2005, 7: 157-164. 10.1038/ncb1216.
Geiger B, Spatz JP, Bershadsky AD: Environmental sensing through focal adhesions. Nat Rev Mol Cell Biol. 2009, 10: 21-33. 10.1038/nrm2593.
Lutz R, Sakai T, Chiquet M: Pericellular fibronectin is required for RhoA-dependent responses to cyclic strain in fibroblasts. J Cell Sci. 123: 1511-1521.
Dzamba BJ, Jakab KR, Marsden M, Schwartz MA, DeSimone DW: Cadherin adhesion, tissue tension, and noncanonical Wnt signaling regulate fibronectin matrix organization. Dev Cell. 2009, 16: 421-432. 10.1016/j.devcel.2009.01.008.
Marsden M, DeSimone DW: Integrin-ECM interactions regulate cadherin-dependent cell adhesion and are required for convergent extension in Xenopus. Curr Biol. 2003, 13: 1182-1191. 10.1016/S0960-9822(03)00433-0.
Aguirre KM, McCormick RJ, Schwarzbauer JE: Fibronectin self-association is mediated by complementary sites within the amino-terminal one-third of the molecule. J Biol Chem. 1994, 269: 27863-27868.
Limper AH, Quade BJ, LaChance RM, Birkenmeier TM, Rangwala TS, McDonald JA: Cell surface molecules that bind fibronectin's matrix assembly domain. J Biol Chem. 1991, 266: 9697-9702.
Sechler JL, Rao H, Cumiskey AM, Vega-Colon I, Smith MS, Murata T, Schwarzbauer JE: A novel fibronectin binding site required for fibronectin fibril growth during matrix assembly. J Cell Biol. 2001, 154: 1081-1088. 10.1083/jcb.200102034.
Maqueda A, Moyano JV, Hernandez Del Cerro M, Peters DM, Garcia-Pardo A: The heparin III-binding domain of fibronectin (III4-5 repeats) binds to fibronectin and inhibits fibronectin matrix assembly. Matrix Biol. 2007, 26: 642-651. 10.1016/j.matbio.2007.06.001.
Abe Y, Bui-Thanh NA, Ballantyne CM, Burns AR: Extra domain A and type III connecting segment of fibronectin in assembly and cleavage. Biochem Biophys Res Commun. 2005, 338: 1640-1647. 10.1016/j.bbrc.2005.10.134.
Chen Y, Wu Y, Cai J: Atomic force microscopic investigation on the potential early intermediate stages of fibrillogenesis of fibronectin within fibrils. Biochem Biophys Res Commun. 2007, 361: 391-397. 10.1016/j.bbrc.2007.07.014.
Craig D, Krammer A, Schulten K, Vogel V: Comparison of the early stages of forced unfolding for fibronectin type III modules. Proc Natl Acad Sci USA. 2001, 98: 5590-5595. 10.1073/pnas.101582198.
Gao M, Craig D, Lequin O, Campbell ID, Vogel V, Schulten K: Structure and functional significance of mechanically unfolded fibronectin type III1 intermediates. Proc Natl Acad Sci USA. 2003, 100: 14784-14789. 10.1073/pnas.2334390100.
Oberhauser AF, Badilla-Fernandez C, Carrion-Vazquez M, Fernandez JM: The mechanical hierarchies of fibronectin observed with single-molecule AFM. J Mol Biol. 2002, 319: 433-447. 10.1016/S0022-2836(02)00306-6.
Hocking DC, Sottile J, McKeown-Longo PJ: Fibronectin's III-1 module contains a conformation-dependent binding site for the amino-terminal region of fibronectin. J Biol Chem. 1994, 269: 19183-19187.
Hocking DC, Smith RK, McKeown-Longo PJ: A novel role for the integrin-binding III-10 module in fibronectin matrix assembly. J Cell Biol. 1996, 133: 431-444. 10.1083/jcb.133.2.431.
Morla A, Zhang Z, Ruoslahti E: Superfibronectin is a functionally distinct form of fibronectin. Nature. 1994, 367: 193-196. 10.1038/367193a0.
Ingham KC, Brew SA, Huff S, Litvinovich SV: Cryptic self-association sites in type III modules of fibronectin. J Biol Chem. 1997, 272: 1718-1724. 10.1074/jbc.272.3.1718.
Bourdoulous S, Orend G, MacKenna DA, Pasqualini R, Ruoslahti E: Fibronectin matrix regulates activation of RHO and CDC42 GTPases and cell cycle progression. J Cell Biol. 1998, 143: 267-276. 10.1083/jcb.143.1.267.
Langenbach KJ, Sottile J: Identification of protein-disulfide isomerase activity in fibronectin. J Biol Chem. 1999, 274: 7032-7038. 10.1074/jbc.274.11.7032.
Chen H, Mosher DF: Formation of sodium dodecyl sulfate-stable fibronectin multimers. Failure to detect products of thiol-disulfide exchange in cyanogen bromide or limited acid digests of stabilized matrix fibronectin. J Biol Chem. 1996, 271: 9084-9089. 10.1074/jbc.271.15.9084.
Ohashi T, Erickson HP: Revisiting the mystery of fibronectin multimers: the fibronectin matrix is composed of fibronectin dimers cross-linked by non-covalent bonds. Matrix Biol. 2009, 28: 170-175. 10.1016/j.matbio.2009.03.002. Epub 2009 Mar 2012
De Jong KL, MacLeod HC, Norton PR, Petersen NO: Fibronectin organization under and near cells. Eur Biophys J. 2006, 35: 695-708. 10.1007/s00249-006-0081-7.
Ohashi T, Kiehart DP, Erickson HP: Dynamics and elasticity of the fibronectin matrix in living cell culture visualized by fibronectin-green fluorescent protein. Proc Natl Acad Sci USA. 1999, 96: 2153-2158. 10.1073/pnas.96.5.2153.
Kubow KE, Klotzsch E, Smith ML, Gourdon D, Little WC, Vogel V: Crosslinking of cell-derived 3D scaffolds up-regulates the stretching and unfolding of new extracellular matrix assembled by reseeded cells. Integr Biol (Camb). 2009, 1: 635-648. 10.1039/b914996a.
Klotzsch E, Smith ML, Kubow KE, Muntwyler S, Little WC, Beyeler F, Gourdon D, Nelson BJ, Vogel V: Fibronectin forms the most extensible biological fibers displaying switchable force-exposed cryptic binding sites. Proc Natl Acad Sci USA. 2009, 106: 18267-18272. 10.1073/pnas.0907518106.
Antia M, Baneyx G, Kubow KE, Vogel V: Fibronectin in aging extracellular matrix fibrils is progressively unfolded by cells and elicits an enhanced rigidity response. Faraday Discuss. 2008, 139: 229-249. discussion 309-225, 419-220
Sakai T, Larsen M, Yamada KM: Fibronectin requirement in branching morphogenesis. Nature. 2003, 423: 876-881. 10.1038/nature01712.
Loots MA, Lamme EN, Zeegelaar J, Mekkes JR, Bos JD, Middelkoop E: Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol. 1998, 111: 850-857. 10.1046/j.1523-1747.1998.00381.x.
Ongenae KC, Phillips TJ, Park HY: Level of fibronectin mRNA is markedly increased in human chronic wounds. Dermatol Surg. 2000, 26: 447-451. 10.1046/j.1524-4725.2000.99281.x.
Diegelmann RF: Cellular and biochemical aspects of normal and abnormal wound healing: an overview. J Urol. 1997, 157: 298-302. 10.1016/S0022-5347(01)65364-3.
van der Straaten HM, Canninga-van Dijk MR, Verdonck LF, Castigliego D, Borst HP, Aten J, Fijnheer R: Extra-domain-A fibronectin: a new marker of fibrosis in cutaneous graft-versus-host disease. J Invest Dermatol. 2004, 123: 1057-1062. 10.1111/j.0022-202X.2004.23474.x.
Muro AF, Moretti FA, Moore BB, Yan M, Atrasz RG, Wilke CA, Flaherty KR, Martinez FJ, Tsui JL, Sheppard D, et al: An essential role for fibronectin extra type III domain A in pulmonary fibrosis. Am J Respir Crit Care Med. 2008, 177: 638-645. 10.1164/rccm.200708-1291OC.
Barnes VL, Musa J, Mitchell RJ, Barnes JL: Expression of embryonic fibronectin isoform EIIIA parallels alpha-smooth muscle actin in maturing and diseased kidney. J Histochem Cytochem. 1999, 47: 787-798. 10.1177/002215549904700608.
Oomura A, Nakamura T, Arakawa M, Ooshima A, Isemura M: Alterations in the extracellular matrix components in human glomerular diseases. Virchows Arch A Pathol Anat Histopathol. 1989, 415: 151-159. 10.1007/BF00784353.
Buyukbabani N, Droz D: Distribution of the extracellular matrix components in human glomerular lesions. J Pathol. 1994, 172: 199-207. 10.1002/path.1711720207.
Babu M, Diegelmann R, Oliver N: Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing. Mol Cell Biol. 1989, 9: 1642-1650.
Chin GS, Liu W, Steinbrech D, Hsu M, Levinson H, Longaker MT: Cellular signaling by tyrosine phosphorylation in keloid and normal human dermal fibroblasts. Plast Reconstr Surg. 2000, 106: 1532-1540. 10.1097/00006534-200012000-00014.
McCarty SM, Syed F, Bayat A: Influence of the human leukocyte antigen complex on the development of cutaneous fibrosis: an immunogenetic perspective. Acta Derm Venereol. 90: 563-574.
Kischer CW, Hendrix MJ: Fibronectin (FN) in hypertrophic scars and keloids. Cell Tissue Res. 1983, 231: 29-37.
Strutz F, Muller GA: Renal fibrosis and the origin of the renal fibroblast. Nephrol Dial Transplant. 2006, 21: 3368-3370. 10.1093/ndt/gfl199.
White ES, Lazar MH, Thannickal VJ: Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis. J Pathol. 2003, 201: 343-354. 10.1002/path.1446.
White ES, Baralle FE, Muro AF: New insights into form and function of fibronectin splice variants. J Pathol. 2008, 216: 1-14. 10.1002/path.2388.
Leask A, Abraham DJ: TGF-beta signaling and the fibrotic response. FASEB J. 2004, 18: 816-827. 10.1096/fj.03-1273rev.
Tomasini-Johansson BR, Kaufman NR, Ensenberger MG, Ozeri V, Hanski E, Mosher DF: A 49-residue peptide from adhesin F1 of Streptococcus pyogenes inhibits fibronectin matrix assembly. J Biol Chem. 2001, 276: 23430-23439. 10.1074/jbc.M103467200. Epub 22001 Apr 23425
Kuo YR, Wu WS, Jeng SF, Wang FS, Huang HC, Lin CZ, Yang KD: Suppressed TGF-beta1 expression is correlated with up-regulation of matrix metalloproteinase-13 in keloid regression after flashlamp pulsed-dye laser treatment. Lasers Surg Med. 2005, 36: 38-42. 10.1002/lsm.20104.
Gabrielli A, Avvedimento EV, Krieg T: Scleroderma. N Engl J Med. 2009, 360: 1989-2003. 10.1056/NEJMra0806188.
Ihn H: Scleroderma, fibroblasts, signaling, and excessive extracellular matrix. Curr Rheumatol Rep. 2005, 7: 156-162. 10.1007/s11926-005-0069-9.
Kusubata M, Hirota A, Ebihara T, Kuwaba K, Matsubara Y, Sasaki T, Kusakabe M, Tsukada T, Irie S, Koyama Y: Spatiotemporal changes of fibronectin, tenascin-C, fibulin-1, and fibulin-2 in the skin during the development of chronic contact dermatitis. J Invest Dermatol. 1999, 113: 906-912. 10.1046/j.1523-1747.1999.00802.x.
Grinnell F, Zhu M: Fibronectin degradation in chronic wounds depends on the relative levels of elastase, alpha1-proteinase inhibitor, and alpha2-macroglobulin. J Invest Dermatol. 1996, 106: 335-341. 10.1111/1523-1747.ep12342990.
Latijnhouwers MA, Bergers M, Veenhuis RT, Beekman B, Ankersmit-Ter Horst MF, Schalkwijk J: Tenascin-C degradation in chronic wounds is dependent on serine proteinase activity. Arch Dermatol Res. 1998, 290: 490-496. 10.1007/s004030050341.
Palolahti M, Lauharanta J, Stephens RW, Kuusela P, Vaheri A: Proteolytic activity in leg ulcer exudate. Exp Dermatol. 1993, 2: 29-37. 10.1111/j.1600-0625.1993.tb00196.x.
Rao CN, Ladin DA, Liu YY, Chilukuri K, Hou ZZ, Woodley DT: Alpha 1-antitrypsin is degraded and non-functional in chronic wounds but intact and functional in acute wounds: the inhibitor protects fibronectin from degradation by chronic wound fluid enzymes. J Invest Dermatol. 1995, 105: 572-578. 10.1111/1523-1747.ep12323503.
Trengove NJ, Stacey MC, MacAuley S, Bennett N, Gibson J, Burslem F, Murphy G, Schultz G: Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen. 1999, 7: 442-452. 10.1046/j.1524-475X.1999.00442.x.
Clark RAF: The Molecular and Cellular Biology of Wound Repair. 1996, New York, N. Y.: Plenum Pres, 2
Shi F, Sottile J: Caveolin-1-dependent beta1 integrin endocytosis is a critical regulator of fibronectin turnover. J Cell Sci. 2008, 121: 2360-2371. 10.1242/jcs.014977.
Bravo-Cordero JJ, Marrero-Diaz R, Megias D, Genis L, Garcia-Grande A, Garcia MA, Arroyo AG, Montoya MC: MT1-MMP proinvasive activity is regulated by a novel Rab8-dependent exocytic pathway. EMBO J. 2007, 26: 1499-1510. 10.1038/sj.emboj.7601606.
Zheng M, Ambesi A, Yu L, McKeown-Longo PJ: Quantification of fibronectin matrix assembly sites using a novel ELISA assay. Matrix Biol. 2007, 26: 330-333. 10.1016/j.matbio.2006.12.004.
Rivera-Torres A: Fibronectin matrix assembly: localization of β1 integrin and effects of laminin on formation of 70-kda fragment linear arrays or fibronectin fibrils. Integrated Biological Sciences Summer Research Program. 2001, University of Wisconsin
Hocking DC, Sottile J, Reho T, Fassler R, McKeown-Longo PJ: Inhibition of fibronectin matrix assembly by the heparin-binding domain of vitronectin. J Biol Chem. 1999, 274: 27257-27264. 10.1074/jbc.274.38.27257.
Sabatelli P, Bonaldo P, Lattanzi G, Braghetta P, Bergamin N, Capanni C, Mattioli E, Columbaro M, Ognibene A, Pepe G, et al: Collagen VI deficiency affects the organization of fibronectin in the extracellular matrix of cultured fibroblasts. Matrix Biol. 2001, 20: 475-486. 10.1016/S0945-053X(01)00160-3.
To WS, Midwood KS: Cryptic domains of tenascin-C differentially control fibronectin fibrillogenesis. Matrix Biol. 2010
To WS, Midwood KS: Identification of novel and distinct binding sites within tenascin-C for soluble and fibrillar fibronectin. J Biol Chem.
Hospenthal MA: Diagnosis and management of idiopathic pulmonary fibrosis: Implications for respiratory care. Respir Care. 2006, 51: 382-391.
Horan GS, Wood S, Ona V, Li DJ, Lukashev ME, Weinreb PH, Simon KJ, Hahm K, Allaire NE, Rinaldi NJ, et al: Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation. Am J Respir Crit Care Med. 2008, 177: 56-65.
Maher TM, Wells AU: Optimal treatment for idiopathic pulmonary fibrosis. Thorax. 2008, 63: 1120-1121. 10.1136/thx.2008.102566. author reply 1121
McCormick LL, Zhang Y, Tootell E, Gilliam AC: Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. J Immunol. 1999, 163: 5693-5699.
Denton CP, Merkel PA, Furst DE, Khanna D, Emery P, Hsu VM, Silliman N, Streisand J, Powell J, Akesson A, et al: Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192. Arthritis Rheum. 2007, 56: 323-333. 10.1002/art.22289.
Fujimoto T, Fujigaki Y, Sun DF, Togawa A, Yonemura K, Hishida A: Important role for fibronectin-EIIIA during renal tubular repair and cellular recovery in uranyl acetate-induced acute renal failure of rats. Virchows Arch. 2003, 443: 194-205. 10.1007/s00428-003-0846-7.
Maniscalco WM, Watkins RH, Chess PR, Sinkin RA, Horowitz S, Toia L: Cell-specific expression of fibronectin and EIIIA and EIIIB splice variants after oxygen injury. Am J Physiol. 1998, 274: L599-609.
Havrlikova K, Mellott M, Kaufman AH, Loredo GA, Peters JH, Colvin RB, Foster CS: Expression of fibronectin isoforms bearing the alternatively spliced EIIIA, EIIIB, and V segments in corneal alkali burn and keratectomy wound models in the rat. Cornea. 2004, 23: 812-818. 10.1097/01.ico.0000133988.34274.24.
Tominaga K, Higuchi K, Watanabe T, Fujiwara Y, Kim S, Arakawa T, Iwao H, Kuroki T: Expression of gene for EIIIA- and EIIIB- fibronectin, fetal types of fibronectin, during gastric ulcer healing in rats. Dig Dis Sci. 2001, 46: 311-317. 10.1023/A:1005541305255.
Vitale AT, Pedroza-Seres M, Arrunategui-Correa V, Lee SJ, DiMeo S, Foster CS, Colvin RB: Differential expression of alternatively spliced fibronectin in normal and wounded rat corneal stroma versus epithelium. Invest Ophthalmol Vis Sci. 1994, 35: 3664-3672.
Matsui S, Takahashi T, Oyanagi Y, Takahashi S, Boku S, Takahashi K, Furukawa K, Arai F, Asakura H: Expression, localization and alternative splicing pattern of fibronectin messenger RNA in fibrotic human liver and hepatocellular carcinoma. J Hepatol. 1997, 27: 843-853. 10.1016/S0168-8278(97)80322-4.
Carnemolla B, Balza E, Siri A, Zardi L, Nicotra MR, Bigotti A, Natali PG: A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. J Cell Biol. 1989, 108: 1139-1148. 10.1083/jcb.108.3.1139.
Birchler MT, Milisavlijevic D, Pfaltz M, Neri D, Odermatt B, Schmid S, Stoeckli SJ: Expression of the extra domain B of fibronectin, a marker of angiogenesis, in head and neck tumors. Laryngoscope. 2003, 113: 1231-1237. 10.1097/00005537-200307000-00023.
Kosmehl H, Berndt A, Strassburger S, Borsi L, Rousselle P, Mandel U, Hyckel P, Zardi L, Katenkamp D: Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma. Br J Cancer. 1999, 81: 1071-1079. 10.1038/sj.bjc.6690809.
Mhawech P, Dulguerov P, Assaly M, Ares C, Allal AS: EB-D fibronectin expression in squamous cell carcinoma of the head and neck. Oral Oncol. 2005, 41: 82-88. 10.1016/j.oraloncology.2004.07.003.
Astrof S, Crowley D, George EL, Fukuda T, Sekiguchi K, Hanahan D, Hynes RO: Direct test of potential roles of EIIIA and EIIIB alternatively spliced segments of fibronectin in physiological and tumor angiogenesis. Mol Cell Biol. 2004, 24: 8662-8670. 10.1128/MCB.24.19.8662-8670.2004.
D'Ovidio MC, Mastracchio A, Marzullo A, Ciabatta M, Pini B, Uccini S, Zardi L, Ruco LP: Intratumoral microvessel density and expression of ED-A/ED-B sequences of fibronectin in breast carcinoma. Eur J Cancer. 1998, 34: 1081-1085. 10.1016/S0959-8049(98)00041-0.
Shiozawa K, Hino K, Shiozawa S: Alternatively spliced EDA-containing fibronectin in synovial fluid as a predictor of rheumatoid joint destruction. Rheumatology (Oxford). 2001, 40: 739-742. 10.1093/rheumatology/40.7.739.
Takasaki I, Chobanian AV, Mamuya WS, Brecher P: Hypertension induces alternatively spliced forms of fibronectin in rat aorta. Hypertension. 1992, 20: 20-25.
Wierzbicka-Patynowski I, Schwarzbauer JE: The ins and outs of fibronectin matrix assembly. J Cell Sci. 2003, 116: 3269-3276. 10.1242/jcs.00670.
Kauf AC, Hough SM, Bowditch RD: Recognition of fibronectin by the platelet integrin alpha IIb beta 3 involves an extended interface with multiple electrostatic interactions. Biochemistry. 2001, 40: 9159-9166. 10.1021/bi010503x.
Hocevar BA, Brown TL, Howe PH: TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 1999, 18: 1345-1356. 10.1093/emboj/18.5.1345.
Qi W, Chen X, Holian J, Mreich E, Twigg S, Gilbert RE, Pollock CA: Transforming growth factor-beta1 differentially mediates fibronectin and inflammatory cytokine expression in kidney tubular cells. Am J Physiol Renal Physiol. 2006, 291: F1070-1077. 10.1152/ajprenal.00013.2006.
Roberts CJ, Birkenmeier TM, McQuillan JJ, Akiyama SK, Yamada SS, Chen WT, Yamada KM, McDonald JA: Transforming growth factor beta stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts. J Biol Chem. 1988, 263: 4586-4592.
Zhang J, Lo C: Regulation of fibronectin expression by PDGF-BB and IGF-I in cultured rat thoracic aortic adventitial fibroblasts. Cell Biol Int. 1995, 19: 517-525. 10.1006/cbir.1995.1096.
Liu Y, Centracchio JN, Lin L, Sun AM, Dworkin LD: Constitutive expression of HGF modulates renal epithelial cell phenotype and induces c-met and fibronectin expression. Exp Cell Res. 1998, 242: 174-185. 10.1006/excr.1998.4107.
Lam S, Verhagen NA, Strutz F, van der Pijl JW, Daha MR, van Kooten C: Glucose-induced fibronectin and collagen type III expression in renal fibroblasts can occur independent of TGF-beta1. Kidney Int. 2003, 63: 878-888. 10.1046/j.1523-1755.2003.00824.x.
Oh JH, Ha H, Yu MR, Lee HB: Sequential effects of high glucose on mesangial cell transforming growth factor-beta 1 and fibronectin synthesis. Kidney Int. 1998, 54: 1872-1878. 10.1046/j.1523-1755.1998.00193.x.
Oliver N, Babu M, Diegelmann R: Fibronectin gene transcription is enhanced in abnormal wound healing. J Invest Dermatol. 1992, 99: 579-586. 10.1111/1523-1747.ep12667776.
Zhang Q, Peyruchaud O, French KJ, Magnusson MK, Mosher DF: Sphingosine 1-phosphate stimulates fibronectin matrix assembly through a Rho-dependent signal pathway. Blood. 1999, 93: 2984-2990.
Quinn JA, Graeber CT, Frackelton AR, Kim M, Schwarzbauer JE, Filardo EJ: Coordinate regulation of estrogen-mediated fibronectin matrix assembly and epidermal growth factor receptor transactivation by the G protein-coupled receptor, GPR30. Mol Endocrinol. 2009, 23: 1052-1064. 10.1210/me.2008-0262.
Vial D, Monaghan-Benson E, McKeown-Longo PJ: Coordinate regulation of fibronectin matrix assembly by the plasminogen activator system and vitronectin in human osteosarcoma cells. Cancer Cell Int. 2006, 6: 8-10.1186/1475-2867-6-8.
Vial D, McKeown-Longo PJ: PAI1 stimulates assembly of the fibronectin matrix in osteosarcoma cells through crosstalk between the alphavbeta5 and alpha5beta1 integrins. J Cell Sci. 2008, 121: 1661-1670. 10.1242/jcs.020149.
Monaghan-Benson E, Mastick CC, McKeown-Longo PJ: A dual role for caveolin-1 in the regulation of fibronectin matrix assembly by uPAR. J Cell Sci. 2008, 121: 3693-3703. 10.1242/jcs.028423.